receptors in T cells β PARP-1 regulates expression of TGF-

[1]  J. Konkel,et al.  Balancing acts: the role of TGF-β in the mucosal immune system. , 2011, Trends in molecular medicine.

[2]  S. Bicciato,et al.  Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells , 2011, Nature Immunology.

[3]  U. Hellman,et al.  PARP-1 attenuates Smad-mediated transcription. , 2010, Molecular cell.

[4]  Todd Davidson,et al.  Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.

[5]  R. Morita,et al.  Smad2 and Smad3 Are Redundantly Essential for the TGF-β–Mediated Regulation of Regulatory T Plasticity and Th1 Development , 2010, The Journal of Immunology.

[6]  W. Kraus,et al.  The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. , 2010, Molecular cell.

[7]  M. Rosado,et al.  Increased Foxp3+ Regulatory T Cells in Poly(ADP-Ribose) Polymerase-1 Deficiency , 2010, The Journal of Immunology.

[8]  Dan R. Littman,et al.  Th17 and Regulatory T Cells in Mediating and Restraining Inflammation , 2010, Cell.

[9]  A. Rudensky,et al.  Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate , 2010, Nature.

[10]  C. Benoist,et al.  Aire's Partners in the Molecular Control of Immunological Tolerance , 2010, Cell.

[11]  M. Greene,et al.  Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. , 2009, Immunity.

[12]  H. Weiner,et al.  Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE , 2009, Nature Immunology.

[13]  W. Deng,et al.  PARP-1 Deficiency Increases the Severity of Disease in a Mouse Model of Multiple Sclerosis* , 2009, The Journal of Biological Chemistry.

[14]  V. Schreiber,et al.  The expanding field of poly(ADP‐ribosyl)ation reactions. ‘Protein Modifications: Beyond the Usual Suspects’ Review Series , 2008 .

[15]  V. Schreiber,et al.  The expanding field of poly(ADP-ribosyl)ation reactions. ‘Protein Modifications: Beyond the Usual Suspects' Review Series , 2008, EMBO reports.

[16]  A. Kulkarni,et al.  A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells , 2008, Nature Immunology.

[17]  J. Yélamos,et al.  Regulation of NFAT by poly(ADP-ribose) polymerase activity in T cells. , 2008, Molecular immunology.

[18]  K. Furuuchi,et al.  Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer , 2008, Nature Immunology.

[19]  L. Dong,et al.  Endogenous TGF-β activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells , 2007, Retrovirology.

[20]  Y. Belkaid,et al.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.

[21]  Y. Belkaid,et al.  Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid , 2007, The Journal of experimental medicine.

[22]  E. Shevach,et al.  Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. , 2007, Blood.

[23]  Yasuhiro Suzuki,et al.  Poly(ADP-ribose) Polymerase-1 Inhibition Prevents Eosinophil Recruitment by Modulating Th2 Cytokines in a Murine Model of Allergic Airway Inflammation: A Potential Specific Effect on IL-51 , 2006, The Journal of Immunology.

[24]  R. Flavell,et al.  Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms , 2006 .

[25]  A. Rudensky,et al.  Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. , 2006, Immunity.

[26]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[27]  J. Sterling,et al.  PARP regulates TGF-beta receptor type II expression in estrogen receptor-positive breast cancer cell lines. , 2006, Anticancer research.

[28]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[29]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[30]  Z. Herceg,et al.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice. , 2004, The Journal of clinical investigation.

[31]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[32]  M. Hottiger,et al.  Transcriptional Coactivation of Nuclear Factor-κB-dependent Gene Expression by p300 Is Regulated by Poly(ADP)-ribose Polymerase-1* , 2003, Journal of Biological Chemistry.

[33]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[34]  J. Lis,et al.  PARP Goes Transcription , 2003, Cell.

[35]  James A. Wright,et al.  Effects of 5‐aminoisoquinolinone, a water‐soluble, potent inhibitor of the activity of poly (ADP‐ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock , 2000, British journal of pharmacology.

[36]  T. Lindahl,et al.  Quality control by DNA repair. , 1999, Science.

[37]  H. Kolb,et al.  Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin , 1999, Nature Medicine.

[38]  S. Snyder,et al.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.

[39]  E. Wagner,et al.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. , 1995, Genes & development.

[40]  Jun Li,et al.  Control of the differentiation of regulatory T cells and TH17 cells by the DNA-binding inhibitor Id3 , 2011, Nature Immunology.

[41]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.